ESG Report 2019

73 B2 . 2 Lost days due to work injury. No disclosure in the Year B3 . 1 Description of occupational health and safety measures adopted, how they are implemented and monitored. No disclosure in the Year B3 . 2 The average training hours completed per employee by gender and employee category. No disclosure in the Year B6 . 1 Percentage of total products sold or shipped subject to recalls for safety and health reasons. Customer Service Management B2 Health and Safety General disclosure on: the policies; and compliance with relevant laws and regulations that have a significant impact on the issuer relating to providing a safe working environment and protecting employees from occupational hazards. Occupational Health and Safety 43-46 B2 . 1 Number and rate of work-related fatalities. Occupational Health and Safety 43-46 B2 . 3 Description of occupational health and safety measures adopted, how they are implemented and monitored. Occupational Health and Safety 43-46 B3 Development and Training General disclosure Policies on improving employees' knowledge and skills for discharging job duties. Description of training activities. Training and Development 38-41 B4 Labour Standards General disclosure on: the policies; and compliance with relevant laws and regulations that have a significant impact on the issuer relating to preventing child and forced labour. Talent Attraction B4 . 1 Description of measures to review employment practices to avoid child and forced labour. Talent Attraction B6 Product Responsibility General disclosure on: the policies; and compliance with relevant laws and regulations that have a significant impact on the issuer relating to health and safety, advertising, labelling and privacy matters relating to products and services provided and methods of redress. Quality Management Product Marketing and Promotion Work and Information Security 13-16; 17; 28-29 B6 . 2 Number of products and service-related complaints received and how they are dealt with. Customer Service Management 18-19 Research, Development and Innovation Protection of Intellectual Property B6 . 3 Description of practices relating to observing and protecting intellectual property rights. 21-23; 24 B6 . 5 Description of consumer data protection and privacy policies, how they are implemented and monitored. Work and Information Security 28-29 B7 Anti-corruption General disclosure on: the policies; and compliance with relevant laws and regulations that have a significant impact on the issuer relating to prevention of bribery, extortion, fraud and money laundering. Building a Culture of Integrity Anti-corruption 31-32; 32 B7 . 1 Number of concluded legal cases regarding corrupt practices brought against the issuer or its employees during the reporting period and the outcomes of the cases. Building a Culture of Integrity 31-32 B5 . 2 Description of practices relating to engaging suppliers, number of suppliers where the practices are being implemented, how they are implemented and monitored. Sustainable Supply Chain Management 26-28 B6 . 4 Description of quality assurance process and recall procedures. Quality Management Customer Service Management 13-16; 18-19 B7 . 2 Description of preventive measures and whistle-blowing procedures, how they are implemented and monitored. Anti-corruption 32 B8 Community Investment General disclosure Policies on community engagement to understand the needs of the communities where the issuer operates and to ensure its activities take into consideration the communities' interests. Facilitating the Development of the Pharmaceutical Industry Giving Back to Society 48-50; 50-52 B8 . 1 Focus areas of contribution (e.g. education, environmental concerns, labour needs, health, culture, sport). Facilitating the Development of the Pharmaceutical Industry Giving Back to Society 48-50; 50-52 B8 . 2 Resources contributed (e.g. money or time) to the focus area. Facilitating the Development of the Pharmaceutical Industry Giving Back to Society Number of suppliers by geographical region. Sustainable Supply Chain Management B5 . 1 B4 . 2 Description of steps taken to eliminate such practices when discovered. B5 Supply Chain Management General disclosure Policies on managing environmental and social risks of the supply chain. Sustainable Supply Chain Management 18-19 Talent Attraction 34-35 26-28 26-28 48-50; 50-52 34-35 34-35 Environmental, Social and Governance Report 2019 The United Laboratories International Holdings Limited ESG Indicators Overview Chapter Page